```html

Quasar‑type Palpitations

What is Quasar‑type palpitations?

Quasar‑type palpitations are a descriptive term used by cardiologists to characterize a sudden, rapid, and forceful heartbeat that feels as though the heart is “bursting” or “shooting” through the chest, similar to the bright, flashing bursts of light from a distant quasar. The sensation is often accompanied by a feeling of “fluttering,” “racing,” or “pounding” that can last from a few seconds to several minutes. Although the term is not a formal diagnosis, it signals an abnormal rhythm that may be benign (e.g., a premature beat) or a sign of a more serious arrhythmia.

In clinical practice, quasar‑type palpitations are most commonly linked to supraventricular tachycardia (SVT) or atrial fibrillation (AFib), but they can also result from electrolyte disturbances, hyperthyroidism, medications, or structural heart disease. Recognizing the pattern, associated symptoms, and triggers helps clinicians determine whether the episode is harmless or requires urgent intervention.

Common Causes

• Supraventricular tachycardia (SVT) – rapid heart rhythms originating above the ventricles, often producing a sudden “jump‑start” feeling.
• Atrial fibrillation or flutter – irregular, often fast rhythms that can feel chaotic and “shimmering.”
• Premature atrial or ventricular contractions (PACs/PVCs) – extra beats that may be felt as a “skip” or “flip” before a strong beat.
• Thyrotoxicosis (overactive thyroid) – excess thyroid hormone can raise heart rate and increase excitability.
• Electrolyte abnormalities – low potassium, magnesium, or calcium can provoke ectopic beats.
• Caffeine, nicotine, or recreational drugs – stimulants that increase sympathetic tone.
• Medications – certain decongestants, asthma inhalers, or anti‑arrhythmic drugs can paradoxically cause rapid rhythms.
• Structural heart disease – such as hypertrophic cardiomyopathy or valvular disease, which can predispose to abnormal conduction.
• Stress, anxiety, or panic attacks – heightened autonomic activity may mimic arrhythmic palpitations.
• Infectious or inflammatory conditions – myocarditis or pericarditis can irritate the heart’s electrical system.

Associated Symptoms

Quasar‑type palpitations rarely occur in isolation. Patients often report one or more of the following:

• Chest discomfort or pressure (often non‑cardiac but can be warning of ischemia)
• Shortness of breath or feeling “out of breath”
• Dizziness, light‑headedness, or near‑syncope
• Cold sweats or clammy skin
• Fatigue after the episode resolves
• Feeling of anxiety or impending doom
• Palatal or throat sensations (“tightness”)
• Occasional nausea or abdominal discomfort

When to See a Doctor

Because palpitations can be a sign of both benign and life‑threatening conditions, it is important to seek medical evaluation when any of the following occur:

• Palpitations last longer than 15–20 minutes or recur frequently.
• They are accompanied by chest pain, pressure, or tightness.
• Sudden fainting, near‑fainting, or severe dizziness.
• Shortness of breath at rest or with minimal exertion.
• Known heart disease (e.g., coronary artery disease, heart failure) and new‑onset palpitations.
• Palpitations after starting a new medication, supplement, or substance.
• Persistent feeling of a “racing heart” that does not settle with rest.

If any of these red‑flag symptoms appear, contact your primary care provider or cardiologist promptly, or go to an emergency department.

Diagnosis

Evaluation is aimed at determining the rhythm, identifying triggers, and ruling out underlying structural or metabolic disease.

Clinical History & Physical Exam

• Detailed description of the episode (onset, duration, frequency, triggers).
• Review of medications, caffeine, alcohol, and illicit drug use.
• Family history of arrhythmias or sudden cardiac death.
• Physical exam focusing on pulse, blood pressure, thyroid size, and signs of heart failure.

Electrocardiogram (ECG)

A 12‑lead ECG performed during symptoms (or as soon as possible afterward) can capture the exact arrhythmia. In many cases, a “baseline” ECG is normal, so clinicians may order a Holter monitor or event recorder.

Monitoring Devices

• Holter monitor (24‑48 h) – continuous recording for short‑term evaluation.
• Event recorder or patch monitor (up to 30 days) – patient‑activated when symptoms occur.
• – used for infrequent but concerning episodes.

Laboratory Tests

• Thyroid‑stimulating hormone (TSH) and free T4 to rule out hyperthyroidism.
• Electrolyte panel (K⁺, Mg²⁺, Ca²⁺).
• Complete blood count and inflammatory markers if infection or anemia is suspected.

Imaging & Specialized Studies

• Echocardiogram – assesses cardiac structure, valve function, and ejection fraction.
• Stress testing – evaluates for ischemia when chest pain is present.
• Cardiac MRI – useful for myocarditis or infiltrative diseases.

Treatment Options

Treatment is directed at the underlying cause and at symptom control. Plans are individualized based on the type of arrhythmia, its frequency, and the patient’s overall health.

Acute Management

• Vagal maneuvers – bearing down, coughing, or the “Valsalva” technique can terminate many SVTs.
• Medication – short‑acting beta‑blockers (e.g., metoprolol) or calcium‑channel blockers (e.g., diltiazem) may be used in the emergency setting.
• Electrical cardioversion – reserved for hemodynamically unstable or sustained tachyarrhythmias.

Long‑Term Therapies

• Beta‑blockers – first‑line for many patients; reduce sympathetic stimulation.
• Calcium‑channel blockers (non‑dihydropyridine) – effective for SVT and rate control in AFib.
• Anti‑arrhythmic drugs – such as flecainide or propafenone for selected SVT patients, prescribed by an electrophysiologist.
• Catheter ablation – curative for many focal SVTs and for atrial fibrillation when medication fails.
• Thyroid management – antithyroid drugs, radioactive iodine, or surgery for hyperthyroidism.
• Electrolyte repletion – oral or IV potassium/magnesium as indicated.
• Lifestyle modification – caffeine reduction, smoking cessation, stress‑management, and regular aerobic exercise.

Home & Self‑Care Strategies

• Keep a symptom diary (time, activity, triggers, heart rate if known).
• Practice paced breathing or mindfulness to lower autonomic tone.
• Avoid large amounts of caffeine (>300 mg/day) and nicotine.
• Stay hydrated; dehydration can provoke ectopic beats.
• Ensure adequate sleep – sleep deprivation increases catecholamine levels.

Prevention Tips

• Regular medical follow‑up – especially if you have known heart disease or thyroid disorders.
• Maintain electrolyte balance – consume potassium‑rich foods (bananas, avocado, leafy greens) and magnesium (nuts, seeds).
• Limit stimulants – caffeine, energy drinks, and over‑the‑counter decongestants.
• Manage stress – yoga, progressive muscle relaxation, or counseling.
• Exercise safely – moderate aerobic activity 150 min/week; avoid extreme endurance sports without physician clearance.
• Medication review – have a pharmacist or doctor evaluate any new prescriptions for pro‑arrhythmic potential.
• Quit smoking – nicotine increases adrenergic drive and can precipitate episodes.
• Screen for sleep apnea – untreated apnea is linked to AFib and other arrhythmias.

Emergency Warning Signs

Key Take‑aways

Quasar‑type palpitations are a vivid description of a rapid, forceful heartbeat that may signal an underlying arrhythmia. While many episodes are benign, they can also herald serious conditions such as SVT, atrial fibrillation, or thyroid disease. Prompt evaluation through history, ECG, and possibly extended monitoring helps pinpoint the cause. Treatment ranges from simple vagal maneuvers and lifestyle changes to medications and catheter ablation. Knowing the warning signs and seeking care promptly can prevent complications and improve quality of life.

---

Sources:

• Mayo Clinic. Palpitations: When to worry. 2023.
• American Heart Association. Understanding Arrhythmias. 2022.
• Cleveland Clinic. Supraventricular Tachycardia (SVT). 2023.
• NIH National Heart, Lung, and Blood Institute. Thyroid Disease and the Heart. 2022.
• European Society of Cardiology. Guidelines for the Management of Atrial Fibrillation. 2020.

```